BioAtla, Inc.BCABNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | -100.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | -100.52% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.05% | +3.99% | +21.13% | +21.34% | +21.54% |
| Weighted Average Shares Diluted Growth | +1.05% | +3.99% | +21.13% | +21.34% | +21.54% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -58.88% | -56.19% | -57.07% | -60.48% | -74.44% |
| Book Value per Share Growth | -76.00% | -80.59% | -99.09% | +0.00% | +0.00% |
| Debt Growth | -56.06% | -66.02% | -71.21% | +263.72% | +394.08% |
| R&D Expense Growth | -42.27% | -48.62% | -34.46% | -15.52% | -41.82% |
| SG&A Expenses Growth | -11.25% | -16.38% | -1.98% | -10.50% | -28.61% |